Hydrix Services Revenue Grows As Singapore Medical Platform Sale Opens Asia-Pacific Market
HYD: $0.003 +0.00% · MC: $3M
Hydrix reported September-quarter Services revenue growth of 12% year on year and 28% from the previous quarter, with contract sales supporting its near-term revenue outlook. It also secured its first Asia-Pacific sale of the Implicity cardiac monitoring platform, a multi-year agreement with Singapore’s National Heart Centre, and delivered an initial milestone under its NIOA defence contract ahead of planned flight trials. The company ended the quarter with approximately $2 million in cash and said delayed customer payments are anticipated to catch up in the December quarter.

Comments